Navigation Links
AvMed Covers H1N1 Flu Vaccine For Members
Date:10/12/2009

MIAMI, Oct. 12 /PRNewswire/ -- AvMed Health Plans announced that it will cover H1N1 flu administration fees for all of its fully insured members. Co-pays, co-insurance and deductibles will not apply for administration of the H1N1 vaccine even if they have a benefit plan that does not include immunizations.

"AvMed is committed to the health and well-being of our members and we want to ensure that the H1N1 national emergency vaccination effort goes as smoothly as possible," said Kirk Cianciolo, D.O., Senior Vice President and Chief Medical Officer of AvMed Health Plans.

Additionally, AvMed is providing members and employers educational materials related to H1N1 virus, including the following current guidelines and information from the Centers for Disease Control and Prevention (CDC):

The CDC is recommending that programs and providers administer the vaccine to persons in the following five target groups (order of target groups does not indicate priority):

  • Pregnant women,
  • Persons who live with or provide care for infants aged <6 months (e.g., parents, siblings, and daycare providers),
  • Health care and emergency medical services personnel,
  • Persons aged 6 months through 24 years, and
  • Persons aged 25 through 64 years who have medical conditions that put them at higher risk for influenza-related complications.

AvMed is closely monitoring the developments related to the H1N1 flu vaccine. For more information, log on to www.avmed.org or www.cdc.gov/h1n1flu.

About AvMed Health Plans

With more than 35 years in Florida, AvMed is one of the state's oldest and largest not-for-profit health plans, and is solely focused on providing health coverage to Florida citizens and businesses. AvMed is one of only a few health plans in the United States that enjoys dual "Excellent" accreditation status for both its commercial and Medicare health plans from the National Committee for Quality Assurance, the nation's top health care quality evaluator. In addition, AvMed has received an "A," or "Excellent" rating by TheStreet.com Ratings, placing it among the top six percent of all health plans in the United States in terms of financial strength.

SOURCE AvMed Health Plans


'/>"/>
SOURCE AvMed Health Plans
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
2. Video: New Research Discovers Independent Brain Networks Control Human Walking
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
7. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
8. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
9. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
10. American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks
11. The Childrens Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohns Disease Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent Marketing ... Up Springboard, an automotive invention that improves the storage features of a pick ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
Breaking Medicine News(10 mins):